Home | Help | Feedback | Subscriptions | Archive | Search | Table of Contents

This Article Full Text Full Text (PDF) Alert me when this article is cited Citation Map Services Email this article Similar articles in this journal Similar articles in PubMed Alert me to new content in the JEM Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via CrossRef Citing Articles via Google Scholar Google Scholar Articles by Klemm, S. Articles by Ruland, J. Search for Related Content PubMed PubMed Citation Articles by Klemm, S. Articles by Ruland, J. Related Collections Related Article Social Bookmarking                      What's this?

The Bcl10–Malt1 complex segregates FcRI-mediated nuclear factor B activation and cytokine production from mast cell degranulation

¹ Third Medical Department, Klinikum rechts der Isar and ² Institute for Medical Microbiology, Immunology, and Hygiene, Technical University of Munich, 81675 Munich, Germany
³ ZAUM-Center for Allergy and Environment, Technical University of Munich and Division of Environmental Dermatology and Allergy, GSF–National Research Center for Environment and Health, 80802 Munich, Germany
⁴ Institute of Clinical Molecular Biology and Tumor Genetics, GSF–National Research Center for Environment and Health, 81377 Munich, Germany
⁵ The Campbell Family Institute for Breast Cancer Research and Ontario Cancer Institute, University Health Network, University of Toronto, Toronto, Ontario, M5G 2C1, Canada

CORRESPONDENCE Jürgen Ruland: jruland{at}lrz.tum.de

Mast cells are pivotal effector cells in IgE-mediated allergic inflammatory diseases. Central for mast cell activation are signals from the IgE receptor FcRI, which induce cell degranulation with the release of preformed mediators and de novo synthesis of proinflammatory leukotrienes and cytokines. How these individual mast cell responses are differentially controlled is still unresolved. We identify B cell lymphoma 10 (Bcl10) and mucosa-associated lymphoid tissue 1 (Malt1) as novel key regulators of mast cell signaling. Mice deficient for either protein display severely impaired IgE-dependent late phase anaphylactic reactions. Mast cells from these animals neither activate nuclear factor B (NF-B) nor produce tumor necrosis factor or interleukin 6 upon FcRI ligation even though proximal signaling, degranulation, and leukotriene secretion are normal. Thus, Bcl10 and Malt1 are essential positive mediators of FcRI-dependent mast cell activation that selectively uncouple NF-B–induced proinflammatory cytokine production from degranulation and leukotriene synthesis.

Abbreviations used: Bcl10, B cell lymphoma 10; BCR, B cell receptor; BMMC, bone marrow–derived mast cell; DNFB, dinitrofluorobenzene; DNP, dinitrophenyl; Erk, extracellular signal–regulated kinase; IB, inhibitor of B; IKK, IB kinase; Iono, ionomycin; Jnk, c-Jun NH2-terminal kinase; Malt1, mucosa-associated lymphoid tissue 1; MAP, mitogen-activated protein; PCA, passive cutaneous anaphylaxis; PKC, protein kinase C; SCF, stem cell factor.

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

Related Article

Two mast cell roads diverge

Heather L. Van Epps
J. Exp. Med. 2006 203: 257a. [Full Text]

This article has been cited by other articles:

• Tiwari, N., Wang, C.-C., Brochetta, C., Ke, G., Vita, F., Qi, Z., Rivera, J., Soranzo, M. R., Zabucchi, G., Hong, W., Blank, U. (2008). VAMP-8 segregates mast cell-preformed mediator exocytosis from cytokine trafficking pathways. Blood 111: 3665-3674 [Abstract] [Full Text]  
• Wegener, E., Krappmann, D. (2007). CARD-Bcl10-Malt1 Signalosomes: Missing Link to NF-{kappa}B. Sci Signal 2007: pe21-pe21 [Abstract] [Full Text]  
• Rueda, D., Gaide, O., Ho, L., Lewkowicz, E., Niedergang, F., Hailfinger, S., Rebeaud, F., Guzzardi, M., Conne, B., Thelen, M., Delon, J., Ferch, U., Mak, T. W., Ruland, J., Schwaller, J., Thome, M. (2007). Bcl10 Controls TCR- and Fc{gamma}R-Induced Actin Polymerization. J. Immunol. 178: 4373-4384 [Abstract] [Full Text]  
• Klemm, S., Zimmermann, S., Peschel, C., Mak, T. W., Ruland, J. (2007). Bcl10 and Malt1 control lysophosphatidic acid-induced NF-{kappa}B activation and cytokine production. Proc. Natl. Acad. Sci. USA 104: 134-138 [Abstract] [Full Text]  
• Chen, Y., Pappu, B. P., Zeng, H., Xue, L., Morris, S. W., Lin, X., Wen, R., Wang, D. (2007). B Cell Lymphoma 10 Is Essential for Fc{epsilon}R-Mediated Degranulation and IL-6 Production in Mast Cells. J. Immunol. 178: 49-57 [Abstract] [Full Text]  
• Gustin, S. E., Thien, C. B. F., Langdon, W. Y. (2006). Cbl-b Is a Negative Regulator of Inflammatory Cytokines Produced by IgE-Activated Mast Cells. J. Immunol. 177: 5980-5989 [Abstract] [Full Text]  
• Klemm, S., Gutermuth, J., Hultner, L., Sparwasser, T., Behrendt, H., Peschel, C., Mak, T. W., Jakob, T., Ruland, J. (2006). The Bcl10-Malt1 complex segregates Fc{varepsilon}RI-mediated nuclear factor {kappa}B activation and cytokine production from mast cell degranulation. J. Cell Biol. 172: i7-i7 [Full Text]  

Home | Help | Feedback | Subscriptions | Archive | Search

TABLE OF CONTENTS